Theravance Biopharma, Inc. (NASDAQ:TBPH) is held by 166 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -18,469 | -0.45% | $0.00 |
| Weiss Asset Management LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Madison Avenue Partners, LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -69,352 | -38.32% | $0.00 |
| Newtyn Management, LLC | 31 Dec, 2025 | 0 | -650,000 | -13.13% | $0.00 |
| Irenic Capital Management LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | -11,963 | -24.46% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 155,771 | 7.04% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 56,255 | 10.94% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 431 | 845.10% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 50,629 | 4.19% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | 262,450 | 124.36% | $0.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 0 | 76,578 | 7.03% | $0.00 |
| Pacer Advisors, Inc. | 31 Dec, 2025 | 0 | 338,958 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 45,987 | 4.36% | $0.00 |
| Trexquant Investment LP | 31 Dec, 2025 | 0 | 37,957 | 26.26% | $0.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 0 | 236,474 | 32.54% | $0.00 |
| Man Group plc | 31 Dec, 2025 | 0 | 37,293 | 46.74% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 40,734 | 4.54% | $0.00 |
| Militia Capital Partners, LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |